Literature DB >> 25164155

Evaluation of the salivary levels of visfatin, chemerin, and progranulin in periodontal inflammation.

Erkan Özcan1, N Işıl Saygun, Muhittin A Serdar, Nezahat Kurt.   

Abstract

OBJECTIVES: In recent years, adipokines have been reported to play an important role in chronic inflammatory diseases. In this study, our aim was to investigate the salivary levels of visfatin, chemerin, and progranulin and their relationship with periodontal health and disease.
MATERIALS AND METHODS: A total of 72 patients were included in the study, 23 of which were periodontally healthy, 24 had gingivitis, and 25 had periodontitis. The clinical periodontal parameters including plaque index (PI), gingival index (GI), probing depth (PD), and clinical attachment levels (CAL) were recorded. Unstimulated saliva samples were collected, and the concentration of adipokines was evaluated using standard enzyme-linked immunosorbent assay.
RESULTS: Salivary visfatin levels were higher in patients with gingivitis and periodontitis compared to those of healthy subjects, while there was no difference between the mean values of gingivitis and periodontitis groups (P > 0.05). There was no difference between the mean values of gingivitis and healthy groups regarding salivary chemerin (P > 0.05), whereas it was detected at higher levels in the periodontitis group compared to the gingivitis and the healthy groups (P < 0.01). Salivary progranulin levels were similar in all groups (P > 0.05). The salivary visfatin level was positively related to PI and GI. The salivary chemerin level was positively related to GI, PD, and CAL.
CONCLUSIONS: These results demonstrated that the higher levels of chemerin in the saliva of patients with periodontitis were correlated with the degree of tissue destruction. CLINICAL RELEVANCE: Chemerin may be a novel biomarker in saliva to determine the severity of periodontal disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25164155     DOI: 10.1007/s00784-014-1308-0

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  44 in total

1.  Association of serum and crevicular visfatin levels in periodontal health and disease with type 2 diabetes mellitus.

Authors:  A R Pradeep; N M Raghavendra; Anuj Sharma; Swati Pradeep Patel; Arjun Raju; Rahul Kathariya; Nishanth S Rao; Savitha B Naik
Journal:  J Periodontol       Date:  2011-10-03       Impact factor: 6.993

2.  Resistin in gingival crevicular fluid and induction of resistin release by Porphyromonas gingivalis lipopolysaccharide in human neutrophils.

Authors:  Y Hiroshima; M Bando; Y Inagaki; C Mihara; M Kataoka; H Murata; Y Shinohara; T Nagata; J Kido
Journal:  J Periodontal Res       Date:  2012-02-06       Impact factor: 4.419

3.  Association of chemerin levels in synovial fluid with the severity of knee osteoarthritis.

Authors:  Ke Huang; Gang Du; Lin Li; Hongsuo Liang; Bo Zhang
Journal:  Biomarkers       Date:  2011-11-14       Impact factor: 2.658

4.  A novel adipocytokine, chemerin exerts anti-inflammatory roles in human vascular endothelial cells.

Authors:  Hideyuki Yamawaki; Satoshi Kameshima; Tatsuya Usui; Muneyoshi Okada; Yukio Hara
Journal:  Biochem Biophys Res Commun       Date:  2012-05-24       Impact factor: 3.575

5.  Chemokine-like receptor-1 expression by central nervous system-infiltrating leukocytes and involvement in a model of autoimmune demyelinating disease.

Authors:  Kareem L Graham; Brian A Zabel; Sanam Loghavi; Luis A Zuniga; Peggy P Ho; Raymond A Sobel; Eugene C Butcher
Journal:  J Immunol       Date:  2009-10-28       Impact factor: 5.422

6.  Increased serum visfatin in patients with metabolic syndrome and carotid atherosclerosis.

Authors:  Ming Zhong; Hong-wei Tan; Hui-ping Gong; Shu-fang Wang; Yun Zhang; Wei Zhang
Journal:  Clin Endocrinol (Oxf)       Date:  2008-03-20       Impact factor: 3.478

7.  Regulation of visfatin by microbial and biomechanical signals in PDL cells.

Authors:  Andressa Vilas Boas Nogueira; Marjan Nokhbehsaim; Sigrun Eick; Christoph Bourauel; Andreas Jäger; Søren Jepsen; Joni Augusto Cirelli; James Deschner
Journal:  Clin Oral Investig       Date:  2013-02-13       Impact factor: 3.573

8.  Serum chemerin is increased in patients with chronic plaque psoriasis and normalizes following treatment with infliximab.

Authors:  P Gisondi; V Lora; C Bonauguri; A Russo; G Lippi; G Girolomoni
Journal:  Br J Dermatol       Date:  2013-02-27       Impact factor: 9.302

9.  Adipokines in psoriatic arthritis patients: the correlations with osteoclast precursors and bone erosions.

Authors:  Yu Xue; Li Jiang; Qingqing Cheng; Haiyan Chen; Yiyun Yu; Yinda Lin; Xue Yang; Ning Kong; Xiaoxia Zhu; Xue Xu; Weiguo Wan; Hejian Zou
Journal:  PLoS One       Date:  2012-10-29       Impact factor: 3.240

10.  Effect of non surgical periodontal therapy on gingival crevicular fluid and serum visfatin concentration in periodontal health and disease.

Authors:  N M Raghavendra; A R Pradeep; Rahul Kathariya; Anuj Sharma; Nishanth S Rao; Savitha B Naik
Journal:  Dis Markers       Date:  2012       Impact factor: 3.434

View more
  9 in total

1.  Serum and salivary levels of chemerin and MMP-9 in oral squamous cell carcinoma and oral premalignant lesions.

Authors:  Noha A Ghallab; Olfat G Shaker
Journal:  Clin Oral Investig       Date:  2016-05-10       Impact factor: 3.573

2.  Evaluation of adipokines and inflammatory mediator expression levels in patients with periodontitis and peri-implantitis: a cross-sectional study.

Authors:  Sila Cagri Isler; Fatma Soysal; Erkan Ozcan; N Isıl Saygun; F Berrin Unsal; Emre Baris; Rahsan Ilikci
Journal:  Clin Oral Investig       Date:  2020-11-12       Impact factor: 3.573

3.  Evaluation of chemerin and its receptors, ChemR23 and CCRL2, in gingival tissues with healthy and periodontitis.

Authors:  Erkan Özcan; N Işıl Saygun; Rahşan Ilıkçı; Yıldırım Karslıoğlu; Uğur Muşabak; Sait Yeşillik
Journal:  Odontology       Date:  2017-02-23       Impact factor: 2.634

4.  Increased visfatin expression is associated with nuclear factor-kappa B and phosphatidylinositol 3-kinase in periodontal inflammation.

Authors:  Erkan Özcan; N Işıl Saygun; Rahşan Ilıkçı; Yıldırım Karslıoğlu; Uğur Muşabak; Sait Yeşillik
Journal:  Clin Oral Investig       Date:  2016-06-09       Impact factor: 3.573

Review 5.  Possible interaction between visfatin, periodontal infection, and other systemic diseases: A brief review of literature.

Authors:  Mojtaba Bayani; Mohammad Pourali; Mohammad Keivan
Journal:  Eur J Dent       Date:  2017 Jul-Sep

6.  Antimicrobial and Attractant Roles for Chemerin in the Oral Cavity during Inflammatory Gum Disease.

Authors:  Urszula Godlewska; Piotr Brzoza; Aneta Sroka; Pawel Majewski; Holger Jentsch; Martin Eckert; Sigrun Eick; Jan Potempa; Brian A Zabel; Joanna Cichy
Journal:  Front Immunol       Date:  2017-03-29       Impact factor: 7.561

7.  Porphyromonas gingivalis lipopolysaccharide affects oral epithelial connections via pyroptosis.

Authors:  Yuyang Li; Baosheng Li; Yujie Liu; Haoyang Wang; Mengxiao He; Yanqun Liu; Yidan Sun; Weiyan Meng
Journal:  J Dent Sci       Date:  2021-01-26       Impact factor: 2.080

Review 8.  Point-of-care diagnosis of periodontitis using saliva: technically feasible but still a challenge.

Authors:  Suk Ji; Youngnim Choi
Journal:  Front Cell Infect Microbiol       Date:  2015-09-03       Impact factor: 5.293

Review 9.  Definitions used for a healthy periodontium-A systematic review.

Authors:  An Li; Renske Z Thomas; Luc van der Sluis; Geerten-Has Tjakkes; Dagmar Else Slot
Journal:  Int J Dent Hyg       Date:  2020-05-24       Impact factor: 2.477

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.